Search Results - "Skalweit, Marion J."

Refine Results
  1. 1
  2. 2

    Substitutions at Position 105 in SHV Family β-Lactamases Decrease Catalytic Efficiency and Cause Inhibitor Resistance by MEI LI, CONKLIN, Benjamin C, TARACILA, Magdalena A, HUTTON, Rebecca A, SKALWEIT, Marion J

    Published in Antimicrobial Agents and Chemotherapy (01-11-2012)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  3. 3

    N152G, -S, and -T Substitutions in CMY-2 β-Lactamase Increase Catalytic Efficiency for Cefoxitin and Inactivation Rates for Tazobactam by Skalweit, Marion J, Li, Mei, Conklin, Benjamin C, Taracila, Magdalena A, Hutton, Rebecca A

    Published in Antimicrobial Agents and Chemotherapy (01-04-2013)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4

    Penicillin Sulfone Inhibitors of Class D β-Lactamases by DRAWZ, Sarah M, BETHEL, Christopher R, BONOMO, Robert A, DOPPALAPUDI, Venkata R, SHERI, Anjaneyulu, SUNDAR RAM REDDY PAGADALA, HUJER, Andrea M, SKALWEIT, Marion J, ANDERSON, Vernon E, CHEN, Shu G, BUYNAK, John D

    Published in Antimicrobial Agents and Chemotherapy (01-04-2010)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  5. 5

    Outpatient Parenteral Antibiotic Therapy in Older Adults by Oliver, Nora T., Skalweit, Marion J.

    “…Outpatient parenteral antimicrobial therapy (OPAT) for older adults is a complex process that involves multiple stakeholders and care coordination, but it is a…”
    Get full text
    Journal Article
  6. 6

    Antibiotic-Resistant Infections and Treatment Challenges in the Immunocompromised Host: An Update by Dumford, 3rd, Donald, Skalweit, Marion J

    “…This article reviews antibiotic resistance and treatment of bacterial infections in the growing number of patients who are immunocompromised: solid organ…”
    Get full text
    Journal Article
  7. 7

    An unusual case of underlying rilpivirine resistance in an antiretroviral-naïve man with AIDS by Skalweit, Marion J

    Published in International journal of STD & AIDS (01-12-2016)
    “…Primary resistance mutations to second generation HIV non-nucleoside reverse transcriptase inhibitors are rare in HIV-infected persons in the US (estimated at…”
    Get more information
    Journal Article
  8. 8

    A rare case of immune reconstitution inflammatory syndrome presenting as secondary syphilis by Khatri, Asma, Skalweit, Marion J

    Published in International journal of STD & AIDS (01-09-2015)
    “…Immune reconstitution syndrome has rarely been reported in the context of syphilis infection. We report a patient with AIDS (CD4 42 cells/mm(3), viral load…”
    Get more information
    Journal Article
  9. 9

    Effect of asparagine substitutions in the YXN loop of a class C β-lactamase of Acinetobacter baumannii on substrate and inhibitor kinetics by Skalweit, Marion J, Li, Mei, Taracila, Magda A

    Published in Antimicrobial agents and chemotherapy (01-03-2015)
    “…Class C cephalosporinases are a growing threat, and inhibitors of these enzymes are currently unavailable. Studies exploring the YXN loop asparagine in the…”
    Get full text
    Journal Article
  10. 10

    Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms by Skalweit, Marion J, Li, Mei

    Published in Drug design, development and therapy (01-01-2016)
    “…Genetic screening of (PSDA) and (ACB) reveals genes that confer increased susceptibility to β-lactams when disrupted, suggesting novel drug targets. One such…”
    Get full text
    Journal Article
  11. 11

    Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections by Skalweit, Marion J

    Published in Drug design, development and therapy (01-01-2015)
    “…Drug-resistant pathogens have gained a foothold especially in the most vulnerable patient populations, hospitalized and immunocompromised individuals…”
    Get full text
    Journal Article
  12. 12

    Ibrutinib Therapy and Mycobacterium chelonae Skin and Soft Tissue Infection by Dousa, Khalid M, Babiker, Ahmed, Van Aartsen, Daniel, Shah, Neel, Bonomo, Robert A, Johnson, John L, Skalweit, Marion J

    Published in Open forum infectious diseases (01-07-2018)
    “…Ibrutinib is an irreversible inhibitor of Bruton's tyrosine kinase approved for the treatment of B-cell malignancies. There is growing concern about the risk…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Enhancing Resistance to Cephalosporins in Class C β-Lactamases: Impact of Gly214Glu in CMY-2 by Endimiani, Andrea, Doi, Yohei, Bethel, Christopher R, Taracila, Magdalena, Adams-Haduch, Jennifer M, O’Keefe, Alexandra, Hujer, Andrea M, Paterson, David L, Skalweit, Marion J, Page, Malcolm G. P, Drawz, Sarah M, Bonomo, Robert A

    Published in Biochemistry (Easton) (09-02-2010)
    “…The biochemical properties of CMY-32, a class C enzyme possessing a single-amino acid substitution in the Ω loop (Gly214Glu), were compared to those of the…”
    Get full text
    Journal Article
  15. 15

    SAME is different: a case report and literature review of Staphylococcus aureus metastatic endophthalmitis by Nixdorff, Neil A, Tang, Johnny, Mourad, Ronda, Skalweit, Marion J

    “…We present a case of methicillin-sensitive Staphylococcus aureus metastatic endophthalmitis (SAME) that developed from a bacteremia. We compare this to a…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Antibiotic-Resistant Infections and Treatment Challenges in the Immunocompromised Host by Dumford, Donald, Skalweit, Marion J.

    “…This article reviews antibiotic resistance and treatment of bacterial infections in the growing number of patients who are immunocompromised: solid organ…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Bulgecin A as a β-lactam enhancer for carbapenem-resistantPseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms by Skalweit, Marion J, Li, Mei

    Published in Drug design, development and therapy (01-01-2016)
    “…Genetic screening of Pseudomonas aeruginosa (PSDA) and Acinetobacter ­baumannii (ACB) reveals genes that confer increased susceptibility to β-lactams when…”
    Get full text
    Journal Article
  20. 20

    715. Bulgecin A lowers Imipenem MICs in Clinical MDR Acinetobacter baumannii (ACB) Strains by Skalweit, Marion J, Rojas, Laura J, Bonomo, Robert A, Dik, David A, Tomoshige, Shusuke, Mobashery, Shahriar

    Published in Open forum infectious diseases (23-10-2019)
    “…Abstract Background Genetic screening of ACB has revealed genes that confer increased susceptibility to β-lactams when these genes are disrupted suggesting…”
    Get full text
    Journal Article